Table 1 Baseline characteristics

From: Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy

 

N =146

Age (years) (±SD)

34 (9)

BMI (kg cm−2) (±SD)

25 (5)

Seminoma n (%)

37/146 (25%)

Non-seminoma n (%)

108/146 (74%)

Unknown n (%)

1/146 (<1%)

Clinical stage

 

 Stadium II n (%)

61/146 (42%)

 Stadium III n (%)

85/146 (58%)

IGCCCG risk groups

 

 Good risk n (%)

97/146 (66%)

 Intermediate risk n (%)

26/146 (18%)

 Poor risk n (%)

23/146 (16%)

Site of metastases

 

 Retroperitoneal lymph nodes

134/146 (92%)

 Lung

61/146 (42%)

 Mediastinal

36/146 (25%)

 Neck

18/146 (12%)

 Visceral

11/146 (8%)

 Bone

4/146 (3%)

 Brain

3/146 (2%)

 Other

9/146 (6%)

AFP (μg l−1) (IQR)

5.70 (2.75–143.50)

HCG (U l−1) (IQR)

7.70 (0.0–1021.1)

LDH (U l−1) (IQR)

445 (324–771)

Haemoglobin (g l−1) (IQR)

146 (133–157)

Leukocytes (103 per μl) (±SD)

7.54 (2.61)

Thrombocytes (103 per μl) (±SD)

289 (100)

Neutrophils (103 per μl) (±SD)

5.08 (2.10)

Lymphocytes (103 per μl) (±SD)

1.47 (0.52)

CRP (mg l−1) (IQR)

5.00 (1.00–20.25)

Albumin (IQR)

43 (39–46)

NLR (IQR)

3.18 (2.34–5.07)

PLR (IQR)

182 (133–167)

SII (IQR)

898 (511–1520)

  1. Abbreviations: AFP=alpha-fetoprotein; BMI=body mass index (kg cm−2); CRP=C-reactive protein (mg l−1); HCG=beta-human chorionic gonadotropin; IGCCCG=International Germ Cell Cancer Collaborative Group; IQR=interquartile range; LDH=lactate dehydrogenase (U l−1); NLR=neutrophil-to-lymphocyte ratio; PLR=platelet-to-lymphocyte ratio; SII=systemic immune-inflammation index.